These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7849234)

  • 1. Variability in the disposition of chlorzoxazone.
    de Vries JD; Salphati L; Horie S; Becker CE; Hoener BA
    Biopharm Drug Dispos; 1994 Oct; 15(7):587-97. PubMed ID: 7849234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired 6-hydroxychlorzoxazone elimination in patients with kidney disease: Implication for cytochrome P450 2E1 pharmacogenetic studies.
    Nolin TD; Gastonguay MR; Bies RR; Matzke GR; Frye RF
    Clin Pharmacol Ther; 2003 Dec; 74(6):555-68. PubMed ID: 14663458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cytochrome P450 2E1 modulators on the pharmacokinetics of chlorzoxazone and 6-hydroxychlorzoxazone in rats.
    Chen L; Yang CS
    Life Sci; 1996; 58(18):1575-85. PubMed ID: 8649187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose disulfiram inhibition of chlorzoxazone metabolism: a clinical probe for P450 2E1.
    Kharasch ED; Thummel KE; Mhyre J; Lillibridge JH
    Clin Pharmacol Ther; 1993 Jun; 53(6):643-50. PubMed ID: 8513656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of 6-hydroxychlorzoxazone as an index of CYP2E1 activity.
    Dreisbach AW; Ferencz N; Hopkins NE; Fuentes MG; Rege AB; George WJ; Lertora JJ
    Clin Pharmacol Ther; 1995 Nov; 58(5):498-505. PubMed ID: 7586943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity.
    O'Shea D; Davis SN; Kim RB; Wilkinson GR
    Clin Pharmacol Ther; 1994 Oct; 56(4):359-67. PubMed ID: 7955797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-performance liquid chromatographic determination of chlorzoxazone and 6-hydroxychlorzoxazone in serum: a tool for indirect evaluation of cytochrome P4502E1 activity in humans.
    Lucas D; Berthou F; Girre C; Poitrenaud F; Ménez JF
    J Chromatogr; 1993 Dec; 622(1):79-86. PubMed ID: 8120116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of diosmin pretreatment on the pharmacokinetics of chlorzoxazone in healthy male volunteers.
    Rajnarayana K; Venkatesham A; Nagulu M; Srinivas M; Krishna DR
    Drug Metabol Drug Interact; 2008; 23(3-4):311-21. PubMed ID: 19326774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on interindividual variations of CYP2E1 using chlorzoxazone as an in vivo probe.
    Vesell ES; Seaton TD; A-Rahim YI
    Pharmacogenetics; 1995 Feb; 5(1):53-7. PubMed ID: 7773304
    [No Abstract]   [Full Text] [Related]  

  • 10. Determination of chlorzoxazone and 6-hydroxychlorzoxazone in human plasma and urine by high-performance liquid chromatography.
    Frye RF; Stiff DD
    J Chromatogr B Biomed Appl; 1996 Nov; 686(2):291-6. PubMed ID: 8971612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of chlorzoxazone as an in vivo probe of cytochrome P450 2E1: choice of dose and phenotypic trait measure.
    Frye RF; Adedoyin A; Mauro K; Matzke GR; Branch RA
    J Clin Pharmacol; 1998 Jan; 38(1):82-9. PubMed ID: 9597564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2E1) and midazolam (CYP3A).
    Palmer JL; Scott RJ; Gibson A; Dickins M; Pleasance S
    Br J Clin Pharmacol; 2001 Nov; 52(5):555-61. PubMed ID: 11736864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive kinetic analysis and influence of reaction components for chlorzoxazone 6-hydroxylation in human liver microsomes with CYP antibodies.
    Yamamura Y; Koyama N; Umehara K
    Xenobiotica; 2015 Apr; 45(4):353-60. PubMed ID: 25815637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of chlorzoxazone in rats with diabetes: Induction of CYP2E1 on 6-hydroxychlorzoxazone formation.
    Baek HW; Bae SK; Lee MG; Sohn YT
    J Pharm Sci; 2006 Nov; 95(11):2452-62. PubMed ID: 16886191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of chlorzoxazone glucuronides via cytochrome P4502E1 dependent and independent pathways in human hepatocytes.
    Quesnot N; Bucher S; Gade C; Vlach M; Vene E; Valença S; Gicquel T; Holst H; Robin MA; Loyer P
    Arch Toxicol; 2018 Oct; 92(10):3077-3091. PubMed ID: 30151596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
    Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T
    Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic parameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administration of chlorzoxazone to liver cirrhotic rats with diabetes mellitus.
    Ahn CY; Bae SK; Jung YS; Lee I; Kim YC; Lee MG; Shin WG
    Drug Metab Dispos; 2008 Jul; 36(7):1233-41. PubMed ID: 18378564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450 2E1 and 3A activities do not differ between Mexicans and European Americans.
    Poland RA; Lin KM; Nuccio C; Wilkinson GR
    Clin Pharmacol Ther; 2002 Sep; 72(3):288-93. PubMed ID: 12235449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasensitive quantification of the CYP2E1 probe chlorzoxazone and its main metabolite 6-hydroxychlorzoxazone in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry after chlorzoxazone microdosing.
    Witt L; Suzuki Y; Hohmann N; Mikus G; Haefeli WE; Burhenne J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():207-13. PubMed ID: 27300008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans.
    Wang Z; Hall SD; Maya JF; Li L; Asghar A; Gorski JC
    Br J Clin Pharmacol; 2003 Jan; 55(1):77-85. PubMed ID: 12534643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.